https://www.selleckchem.com/pr....oducts/talabostat.ht
73; 95% confidence interval [CI], 0.55-0.97, p=.04). Additionally, individuals who received treatment at hospitals that were successful competitors had a lower risk of a 90-day readmission following rectal cancer surgery (OR, 0.86; 95% CI, 0.76-0.97, p=.03) and were less likely to have a persistent stoma at 18months after anterior resection (OR, 0.75; 95% CI, 0.61-0.93, p=.02). Hospitals located in areas of high competition are associated with better patient outcomes and improved processes of care for rectal cancer surgery. Hospitals
Aimer
Commentaire
Partagez
